# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects

> **NCT07057726** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Shenyang Sunshine Pharmaceutical Co., LTD.** · enrollment: 48 (estimated)

## Conditions studied

- Safety and Tolerability in Healthy Volunteers

## Interventions

- **DRUG:** SSS39
- **DRUG:** SSS39

## Key facts

- **NCT ID:** NCT07057726
- **Lead sponsor:** Shenyang Sunshine Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-10-09
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07057726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07057726, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07057726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*